TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to ove...
Leadership
James A. Bianco M.D.
President, CEO & Director
Dan Dearborn CPA
Executive VP of Finance & CFO
Michael LawmanFounder
Co-Founder
Patricia LawmanFounder
Co-Founder
Michael Krsulich
Head of Quality Assurance
Bertrand Le Bourdonnec Ph.D.
Executive VP, Head of Drug Discovery, Early Development, & Program Management
